Use of antiplatelet inhibitors in peripheral vascular interventions.

about

Use of antiplatelet inhibitors in peripheral vascular interventions.

Item

http://www.wikidata.org/entity/Q42118681

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Use of antiplatelet inhibitors in peripheral vascular interventions.

@en

Use of antiplatelet inhibitors in peripheral vascular interventions.

@nl

type

Item

label

Use of antiplatelet inhibitors in peripheral vascular interventions.

@en

Use of antiplatelet inhibitors in peripheral vascular interventions.

@nl

prefLabel

Use of antiplatelet inhibitors in peripheral vascular interventions.

@en

Use of antiplatelet inhibitors in peripheral vascular interventions.

@nl

P1476

Use of antiplatelet inhibitors in peripheral vascular interventions

@en

P2093

S William Stavropoulos

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

Incidence of intracranial hemorrhage complicating treatment with glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis of major clinical trials.

Readministration of abciximab: interim report of the ReoPro readministration registry.

Platelet glycoprotein IIb/IIIa antagonists. What are the relevant issues concerning their pharmacology and clinical use?

Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment.

Efficacy of abciximab readministration in coronary intervention.

Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: preliminary experience.

Thrombotic thrombocytopenic purpura associated with clopidogrel.

P304

80-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1055/S-2005-871862

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Richard D Shlansky-Goldberg

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49841301

http://www.w3.org/2001/XMLSchema#string

P698

21326677

http://www.w3.org/2001/XMLSchema#string

P932

3036273

http://www.w3.org/2001/XMLSchema#string